Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial for TP-271
19 janv. 2016 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Jan. 19, 2016 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the initiation of patient dosing in a phase 1 clinical trial for intravenous (IV)...
Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference
03 déc. 2015 09h11 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals to Provide Corporate Update at Stifel 2015 Healthcare Conference
12 nov. 2015 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Reports Third-Quarter 2015 Financial Results
02 nov. 2015 07h30 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Nov. 2, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Eravacycline Data Supporting Activity Against Multidrug-Resistant Gram-Negative Bacteria to be Presented at IDWeek 2015
07 oct. 2015 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Announces Top-Line Results From IGNITE2 Phase 3 Clinical Trial of Eravacycline in cUTI
08 sept. 2015 16h01 HE
|
Tetraphase Pharmaceuticals, Inc.
Eravacycline Did Not Achieve Primary Endpoint in Pivotal Portion of cUTI Trial
Company to Host Conference Call at 4:30 p.m. ET Today
WATERTOWN, Mass., Sept. 8, 2015 (GLOBE NEWSWIRE) --...
FDA Grants QIDP Designation and Fast Track Status to TP-271
03 sept. 2015 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious...
Tetraphase Pharmaceuticals to Present Antibiotics Pipeline Data at ICAAC/ICC 2015
25 août 2015 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Aug. 25, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that 11 data presentations at the Interscience Conference of Antimicrobial Agents and...
Tetraphase Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference
06 août 2015 08h00 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
Tetraphase Pharmaceuticals Reports Second-Quarter 2015 Financial Results
05 août 2015 16h01 HE
|
Tetraphase Pharmaceuticals, Inc.
WATERTOWN, Mass., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...